-
Founded in:
1997-03-12 -
Country:
China -
Address:
No. 7, Keyuan South Road, Qibuli Park, Chengdu Hi-tech Zone -
Tax NO.:
91510100633122307J -
Registered Funds:
512.687899 yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| human immunoglobulin |
Immunoglobulin injection is a passive immunotherapy that transfers a large amount of antibodies contained in immunoglobulin to the recipient, allowing the recipient to quickly reach a temporary immune protection state from a low or no immune state. The interaction between antibodies and antigens directly neutralizes toxins and kills bacteria and viruses, so it has a certain effect on preventing bacterial and viral infections.
More
Immunoglobulin injection is a passive immunotherapy that transfers a large amount of antibodies contained in immunoglobulin to the recipient, allowing the recipient to quickly reach a temporary immune protection state from a low or no immune state. The interaction between antibodies and antigens directly neutralizes toxins and kills bacteria and viruses, so it has a certain effect on preventing bacterial and viral infections. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| human immunoglobulin |
Immunoglobulin injection is a passive immunotherapy that transfers a large amount of antibodies to the recipient, allowing the recipient to quickly reach a temporary immune protection state from a low or no immune state. The interaction between antibodies and antigens directly neutralizes toxins and kills bacteria and viruses, and has a certain effect on preventing bacterial and viral infections.
More
Immunoglobulin injection is a passive immunotherapy that transfers a large amount of antibodies to the recipient, allowing the recipient to quickly reach a temporary immune protection state from a low or no immune state. The interaction between antibodies and antigens directly neutralizes toxins and kills bacteria and viruses, and has a certain effect on preventing bacterial and viral infections. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Human Hepatitis B immunoglobulin BRP |
This product contains high titer hepatitis B surface antibodies, which can specifically bind to the corresponding antigens to play a role in passive immunity.
More
This product contains high titer hepatitis B surface antibodies, which can specifically bind to the corresponding antigens to play a role in passive immunity. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Human Hepatitis B immunoglobulin BRP |
Hepatitis B immunoglobulin is selected from healthy blood donors, whose plasma contains high titer of hepatitis B surface antibodies, and is made into high titer hepatitis B immunoglobulin through concentration process. It is used to block mother-to-child transmission and prevent hepatitis B virus infection under special circumstances.
More
Hepatitis B immunoglobulin is selected from healthy blood donors, whose plasma contains high titer of hepatitis B surface antibodies, and is made into high titer hepatitis B immunoglobulin through concentration process. It is used to block mother-to-child transmission and prevent hepatitis B virus infection under special circumstances. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Human Fibrinogen |
During the coagulation process, fibrinogen is hydrolyzed by thrombin into fibrin. Under the action of fibrin-stabilizing factor (FXIII), solid fibrin is formed, which plays an effective hemostatic role.
More
During the coagulation process, fibrinogen is hydrolyzed by thrombin into fibrin. Under the action of fibrin-stabilizing factor (FXIII), solid fibrin is formed, which plays an effective hemostatic role. |
0 |